The phospholipid transfer protein (PLTP) may play a role in body fat regulation. OBJECTIVE: To investigate the association between PLTP genetic variants and obesity-related phenotypes. METHODS: Two intronic variants, one in intron 1 (c.À87G4A) and the other in intron 12 (c.1175 þ 68T4G), were genotyped in 811 participants of the Québec Family Study. Nine obesity-related phenotypes were investigated, including body mass index (BMI), obesity (BMIZ30 kg/m 2 ), and waist circumference, percentage of fat, fat mass and fat-free mass measured by hydrostatic weighing as well as total, visceral and subcutaneous abdominal adipose tissue areas assessed by computed tomography. Single markers and haplotypes were tested for associations in family-based designs using the FBAT program. RESULTS: The SNP located in intron 1 showed significant associations with obesity, BMI, waist circumference and fat-free mass (Po0.05). The low-frequency allele (A allele) was associated with higher trait values, suggesting that the transmission of this allele is associated with an increased risk of being obese. Significant associations were observed between haplotypes and obesity, waist circumference, percentage of fat and fat-free mass (Po0.05). The transmission of the AT haplotype (frequency ¼ 0.180) was positively associated with obesity-related phenotypes. After sequencing the promoter and the coding regions of the PLTP gene, we were unable to identify a mutation that could replicate these results. CONCLUSION: Intronic variants of the PLTP gene are significantly associated with obesity-related phenotypes. Considering the number and the relevance of candidate genes surrounding the PLTP locus and the absence of missense polymorphisms in the coding region, the associations could be mediated by a second gene allele in linkage disequilibrium with the marker locus.
Introduction
The phospholipid transfer protein (PLTP), also referred to as lipid transfer protein 2, belongs to the lipopolysaccharidebinding/lipid transfer protein family, together with cholesteryl ester transfer protein, lipopolysaccharide-binding protein and bactericidal/permeability-increasing protein.
The PLTP gene is mapped to chromosome 20q12-q13.1 1 and encodes a mature protein of 476 residues. 2 The PLTP mRNA transcript is detectable in a wide variety of tissues including pancreas, lung, kidney, heart, liver, skeletal muscle and brain. 3 The transcript is also highly expressed in adipose tissues with a significant depot-related difference between subcutaneous and visceral adipose tissues. 4, 5 The predicted model structure of PLTP consists of two lipid-binding pockets characterized by apolar residues, with an N-terminal pocket critical for PLTP transfer activity and a C-terminal pocket involved in lipid binding. 6, 7 The initial physiological function ascribed to plasma PLTP was one of transfer of the phospholipids from triglyceriderich lipoproteins to high-density lipoproteins (HDL) during lipolysis. 8 Since then, animal and human studies have suggested that plasma PLTP level is an important factor in lipoprotein/lipid metabolism and atherosclerosis development. 9, 10 More recently, PLTP activity has been reported to be positively and independently related to coronary artery disease. 11 Despite these physiological insights, our understanding of the role of PLTP in human metabolism and particularly the function of peripheral PLTP is poorly understood. Recently, it has been suggested that PLTP might play a role in the regulation of body fat content. First, the mRNA levels and the activity of PLTP have been consistently associated with obesity. 4, [12] [13] [14] [15] However, the mechanism of this association between PLTP and obesity is not fully understood. Kaser et al 12 have proposed that the increased synthesis of the protein may be the result of the enlarged mass of adipose tissue. This has been supported by Murdoch et al 16 who reported that PLTP activity is decreased following a diet-induced weight loss. Secondly, the inactivation of the PLTP gene in Caenorhabditis elegans by RNA interference causes an increase in fat storage, suggesting that loss-offunction mutations in mammalian homolog could lead to obesity. 17 Third, two independent genome-wide scans provided significant evidence of linkage with obesity-related phenotypes within the PLTP region. 18, 19 In addition, several mouse studies have suggested that genes influencing body fatness in mice reside on chromosome 2 in a region homologous to human chromosome 20q. [20] [21] [22] Finally, it has been shown that PLPT facilitates the production of triglyceride-rich apoB-containing lipoproteins 23, 24 and the transport of lipids from cells, 25 which are central functions of lipid homeostasis. Based on these observations, we hypothesize that PLTP modulates the level of adiposity. To test this hypothesis, we investigated the association between PLTP genetic variants and obesity-related phenotypes.
Methods

Subjects
Subjects were from the Québec Family Study (QFS), a cohort of French-Canadian families representing a mixture of random sampling and sampling through an obese proband. This project was specifically designed to understand the genetic basis of obesity and its comorbidities. Details of recruitment procedures have been published. 26 Only adults, 18 y and older, were considered for the present study. Table 1 presents the characteristics of the subjects. The Laval University Medical Ethics Committee approved the study, and all subjects provided written informed consent.
Anthropometry, body composition and fat distribution measurements Body weight, height and waist circumference were measured following standardized procedures. 27 Body density was measured by the hydrostatic weighing technique. 28 Pulmonary residual volume was assessed before immersion in the hydrostatic tank, using the helium dilution technique of Meneely and Kaltreider. 29 The percentage of body fat, fat mass and fat-free mass were derived from body density using the Siri equation. 30 Finally, a cross-sectional abdominal scan was performed by computed tomography using a Somatom DRH scanner (Siemens, Erlanger, Germany) to quantify abdominal total, subcutaneous and visceral adipose tissue areas between L4 and L5 vertebrae as described in detail elsewhere. 31 
SNP selections and genotyping
To explore the possible involvement of PLTP in obesityrelated phenotypes, we genotyped two variants previously reported in dbSNP (rs394643 and rs553359) (Figure 1 ). These SNPs were chosen based on the number of chomosomes tested and their average estimated heterozygosity. They are defined as c.À87G4A (denoting an intronic G to A substitution located 87 nucleotides downstream of the start codon) and c.1175 þ 68T4G (denoting an intronic T to G substitution located 68 nucleotides upstream of the last nucleotide of exon 12) according to the nomenclature recommendations. 32 A total of 898 and 893 subjects were genotyped for the c.À87G4A and c.1175 þ 68T4G polymorphisms, respectively. Genotyping was performed using a minisequencing (ms) assay. 33 PCR primers (forward (f), reverse (r)) and ms primers were as follows: rs553359 (324 bp), fF5 
0 -GACGTCCAACCATAAGTGGG-3 0 . PCR conditions were as follows: In final volume of 6 ml, 20 ng of genomic DNA were added to a mixture containing a final concentration of dNTP (Amersham Pharmacia Biotech Inc.), 30 mM each; Taq DNA polymerase (Qiagen), 0.3 U; buffer 1 Â [10 Â : Tris-HCl, KCl, (NH 4 ) 2 SO 4 and 15 mM MgCl 2 ; pH 8.7 (201C)); MgCl 2 , 2.25 mM; and flanking primers, 50 nM each. Following a 5-min denaturation step at 951C, 30 PCR amplification cycles were performed as follows: denaturation at 951C, 20 s, annealing 601C, 1 min; for 10 cycles; and denaturation at 951C, 20 s, annealing at 571C, 1 min, for the remaining 20 cycles. In the same well, the PCR mixture dNTP's was digested using Shrimp Alkaline Phosphatase (USB), 0.2 U (final volume: 11 ml) for 15 min at 371C followed by 20 min at 801C. Ms assay was performed in a final volume of 16 ml (in the same well); dTTP/ddNTP mix (dTTP, ddATP, ddCTP and ddGTP) for rs553359 and dGTP/ddNTP mix (dGTP, ddATP, ddTTP and ddCTP) for rs 394643 (dNTP and ddNTP are from Amersham Pharmacia Biotech Inc.), 1.56 mM each; IRDye tag primer, 3.125 nM (LICOR); Thermosequenase (USB), 0.3 U; 0.6 Â buffer (10 Â : Tris-HCl, 260 mM, MgCl 2 , 65 mM, pH 9.5) were added to microplates. Following 2 min denaturation step at 951C, 30 PCR amplification cycles were performed as follows: denaturation at 951C, 10 s; annealing at 601C, 30 s; extension at 721C, 5 s. Detection was carried out on a LICOR automated sequencer model 4200.
Sequencing
The promoter and the coding regions of the PLTP gene were sequenced in 19 subjects with different genotypes for the intronic variants and with different degrees of obesity. All exons and exon-intron splicing boundaries were amplified from genomic DNA by use of specific primers derived from the 5 0 -and 3 0 -ends of intronic sequence. We also sequenced up to 230 bp downstream from the first transcriptional initiation site responsible for the full promoter activity. 34 Owing to the particular genomic structure of the PLTP gene, characterized by the presence of small introns, some exons were amplified within the same fragment. Table 2 presents the specific primers for each fragment with their product size. All primers were designed using the Primer 3.0 software available on the Whitehead Institute/MIT Center for Genome Research server (http://www-genome.wi.mit.edu/ cgi-bin/primer/primer3.cgi). Amplification was performed by polymerase chain reaction using a thermal cycler, model PTC-200 (MJ Research, Watertown, MA, USA). The cycler was programmed at 951C for 5 min followed by 35 cycles of the following 3 min: 1 min at 951C for denaturation, 1 min at annealing temperature and 1 min at 721C for elongation. The sequence was completed with 10 min at 721C The annealing temperature was optimized for each pair of primers by performing a 53-671C gradient assay using stock DNA (see Table 2 ). PCR conditions were as follows: reaction volume was 50 ml including 0.2 ml of AmpliTaq s DNA polymerase (Perkin-Elmer Cetus), 5 ml of 10Â PCR buffer and 2.5 mM of MgCl 2 as recommended by the manufacturer, 0.2 mM of dNTPs, 8.4 ml of each primer at a final concentration of 7.5 mM and 6 ml of genomic DNA at a final concentration of 20 ng/ml. PCR products were purified by the ABI ethanol-EDTA precipitation protocol, collected using a Beckman-Coulter Allegra 6R centrifuge and resuspended in a 50% HiDi-formamide solution. Sequence reactions were performed using the BigDye TH Terminator v3.1 kit and samples were run on ABI Prism s 3730/XL DNA Associations between single SNPs and the obesity-related phenotypes were tested using a family-based association test. The results of these analyses are presented in Table 3 . The w 2 statistics with its 1 df corresponding P-value are presented for each obesity-related phenotypes. In addition, the effect of the low-frequency allele (allele A for the c.À87G4A polymorphism and allele G for the c.1175 þ 68T4G polymorphism) on the trait values are indicated, based on the Z-statistic provided by the univariate test performed for each allele. Of interest to note, since we are dealing with biallelic markers, the P-values associated with the Z-statistic are the same as those of the w 2 statistic (the two tests are equivalent). The SNP in intron 1 (c.À87G4A) showed significant associations with obesity, BMI, waist circumference and fat-free mass. The Z-statistics for allele A were positive for all obesity-related phenotypes, suggesting that this allele increases the risk of being obese. On the other hand, no associations were observed between the c.1175 þ 68T4G polymorphism and the various phenotypes.
Haplotype association tests for family-based studies were also performed (Figure 2 ). For each haplotype, the Z-statistic is presented for the dichotomous (obesity) and the eight quantitative phenotypes. The haplotype frequencies were as follows: GT ¼ 0.468, AG ¼ 0.286, AT ¼ 0.180 and GG ¼ 0.066. The AT haplotype was significantly and positively associated with obesity, waist circumference, percent body fat and fat-free mass (Po0.05), suggesting that it is a high-risk haplotype. The same trend (Po0.1) was observed for BMI, fat mass and subcutaneous adipose tissue areas. On the other hand, the GT haplotype seems to be weakly protective against obesity but only the waist circumference phenotype reached statistical significance (Po0.05). 
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In an attempt to identify a functional mutation in the PLTP gene that could account for these results, we sequenced the coding and the promoter regions of the gene. In addition to the two genotyped polymorphisms (rs394643 and rs553359), we identified three SNPs (Figure 1 ): 1Ftwo heterozygous subjects for a C4G substitution in intron 1 (c.À601C4G) of the gene, which was already in dbSNP (rs2294213); 2Fone heterozygous subject carries a C4T substitution in intron 2 (C.100 þ 42C4T); and 3Fone heterozygous subject carries a G4A substitution in exon 6 (c.537G4A), which is a synonymous change. These three SNPs are located at position 84449, 83707 and 80249 in the DNA genomic sequence AL008726 (GenBank accession number), respectively. It is unlikely that these rare variants would play any role in significant associations observed herein between the PLTP intronic polymorphisms and obesity-related phenotypes.
Discussion
In this study, we performed family-based tests of association between PLTP genetic variants and obesity-related phenotypes. Two SNP polymorphisms were genotyped, one located in intron 1 (c.À87G4A) and the second in intron 12 (c.1175 þ 68T4G). Single-marker association tests revealed significant associations between the SNP in intron 1 and several indices of adiposity, including BMI (both as a quantitative trait and as a dichotomous trait with a cut off at Z30 kg/m 2 ), and waist circumference. In these analyses, the transmission of the low-frequency allele (A allele) was associated with increased trait values. Despite partial linkage disequilibrium with the SNP in intron 1, the SNP in intron 12 provided no evidence of association with any obesity-related phenotypes. Since multimarker haplotypes are likely to yield more genetic information than the study of a single marker, we also performed haplotype association tests for familybased study. Again significant associations were observed for some haplotypes. Indeed, the transmission of the AT haplotype appears to increase the likelihood of being obese.
A significant association test could be the result of a functional variant in a gene in linkage disequilibrium with the marker. We thus verified this hypothesis by sequencing the promoter and coding regions of the PLTP gene in subjects with different genotypes for the intronic variants and with different degrees of obesity. Three additional variants were identified, the first located in the 5 0 -untranslated region (c.À601C4G), the second in intron 2 (c.100 þ 42C4T) and the last in exon 6 (c.537G4A) (Figure 1 ). None of these SNPs changed the amino-acid sequence of the protein and their low frequencies make them unlikely candidates to account for the associations observed herein. We are therefore left with two other potential explanations. The functional mutation in linkage disequilibrium with the intronic markers lies elsewhere upstream or downstream from the PLTP coding sequence. On the other hand, one could speculate that the intronic markers are themselves functional. Recently, it has been demonstrated that a silent substitution in intron 11 of the lamin A gene causes a rare disorder, called Hutchinson-Gilford Progeria Syndrome, that results in premature aging and shortened lifespan. 38 Intronic
SNPs have also been associated with rheumatoid arthritis 39 and myocardial infarction. 40 If a silent mutation can produce such severe phenotypes, subtle effects from this type of mutation are also likely to be observed. However, there are as of yet no functional studies evaluating the effect of intronic variants on the protein products. Different mechanisms could explain the association between PLTP and obesity-related phenotypes. First, the gene transcript and the activity of PLTP have been consistently related to obesity. 4, [12] [13] [14] [15] However, these studies were based on correlations and cannot establish a cause and effect relation. Although it has been suggested that PLTP activity is influenced by body weight, 12, 16 we could hypothesize that PLTP itself is responsible for this close relationship. Important functions governing lipid homeostasis have been ascribed to PLTP. In addition to its well-established role in mediating the transfer of phospholipids between triglyceriderich lipoproteins and HDL in the intravascular compartment, 8 hepatic PLTP in mice has been shown to play a major role in regulating the secretion of apoB-containing lipoproteins. 24 Furthermore, peripheral PLTP is also known to enhance the cellular efflux of lipids. For instance, Wolfbauer et al 41 have demonstrated that PLTP increases cholesterol and phospholipid efflux from cholesterol-loaded human fibroblasts. Subsequently, the same group reported similar observations in murine macrophages and hamster kidney cells and showed that PLTP mediates its effect via the ATPbinding cassette transporter A1 (ABCA1) pathway. 25 This process might play an important role in enhancing flux of lipids from tissues. Given the expression of ABCA1 42 and PLTP 4 in the adipose tissue, such a transport mechanism could alternate lipid storage into adipocytes, which is the long-term process leading to obesity. It is possible that the PLTP allele significantly associated with obesity-related phenotypes in our study is not causative. The associations may arise because of a second gene allele in linkage disequilibrium with the PLTP marker locus. In proximity of the PLTP gene, there are multiple candidate genes. 43 The melanocortin 3 receptor and the adenosine deaminase, located approximately 10.3 and 1.3 Mb from the PLTP gene, respectively, have been significantly associated with obesity-related phenotypes. 44, 45 The agouti signaling protein (ASIP) is also located within the relevant region of human chromosome 20. The ASIP is the human ortholog of the mouse agouti gene, which is a single-gene mutation model of obesity. 46 Finally, three candidate genes located in the vicinity of the PLTP locus, namely the CCAAT enhancerbinding protein, the protein tyrosine phosphatase-1B, and the growth hormone-releasing hormone have been identified as obesity-modifying genes in knockout and transgenic experiments. [47] [48] [49] Thus, it is possible that the significant PLTP and obesity Y Bossé et al associations observed in the present study are due to an allele in a second gene in linkage disequilibrium with the marker locus.
In conclusion, we reported here for the first time significant associations between PLTP genetic variants and obesity-related phenotypes. The associations were evidenced using both single-locus and haplotypes analyses based on family study. Based on the sequencing of all exons and the promoter region of the gene, we were unable to identify a mutation that could explain the significant associations with the intronic variants. Although some evidence suggested that PLTP itself may be responsible for the association, the number of candidate genes surrounding the PLTP locus suggests that an allele in a second gene in linkage disequilibrium with the PLTP markers could be responsible for the associations. Further studies are required to clarify this issue.
